The medical device affairs outsourcing market size has grown strongly in recent years. It will grow from $5.45 billion in 2025 to $5.85 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing regulatory complexities, reliance on in-house regulatory teams, growing number of medical device approvals, expansion of global medical device markets, rising awareness of compliance risks.
The medical device affairs outsourcing market size is expected to see strong growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of advanced regulatory software solutions, growth in outsourcing partnerships, increasing focus on strategic regulatory planning, expansion of post-market surveillance programs, integration of ai and analytics for regulatory efficiency. Major trends in the forecast period include increasing adoption of regulatory affairs outsourcing by medical device companies, rising demand for cloud-based compliance and management solutions, focus on streamlining clinical trial applications and regulatory submissions, growth in quality management system (qms) support services, enhanced post-market surveillance and risk assessment capabilities.
The increasing demand for medical devices is increasingly supporting the expansion of the medical device affairs outsourcing market going forward. Medical devices include instruments, machines, implants, and apparatuses used to diagnose, treat, or prevent medical conditions. Demand for medical devices continues to rise due to improved treatment outcomes, enhanced patient care, and expansion of healthcare infrastructure. Medical device affairs outsourcing supports manufacturers by improving regulatory compliance, streamlining operations, and accelerating market access, enabling companies to focus on innovation and core competencies. For example, in April 2024, according to the Medicines and Healthcare products Regulatory Agency, a UK-based government agency, the number of registered medical products increased from approximately 2.25 million in 2022 to around 3.25 million in 2024. As a result, the growing demand for medical devices is reinforcing expansion across the medical device affairs outsourcing market.
Leading companies operating in the medical device affairs outsourcing market are strengthening decentralized clinical trial capabilities to improve research efficiency, patient recruitment, and data quality. Decentralized clinical trials use digital tools and remote participation to enhance flexibility and accessibility while maintaining regulatory compliance. For example, in March 2023, Syneos Health, a US-based provider of contract research and commercialization services, launched a Decentralized Clinical Trial Site Network to support broader adoption of decentralized trial models. This initiative enhances trial quality, patient engagement, and evidence generation for medical device commercialization.
In June 2023, Arterex Medical, a US-based provider of medical device contract manufacturing services, acquired NextPhase Medical Devices LLC for an undisclosed amount. With this acquisition, Arterex enhances its manufacturing capabilities and positions itself for future growth in a competitive market environment. NextPhase Medical Devices LLC is a US-based company that offers medical device regulatory and quality affairs outsourcing services.
Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC.
Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device affairs outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the medical device affairs outsourcing market by increasing costs for imported software platforms and consulting services used for regulatory compliance. Segments such as cloud-based software solutions and regulatory consulting are most affected, particularly in regions like Asia-Pacific and Europe where outsourcing hubs rely on imported technology and expertise. While tariffs have created cost pressures and operational adjustments, they also encourage local development of regulatory tools and services, fostering innovation and domestic capacity building.
The medical device affairs outsourcing market research report is one of a series of new reports that provides medical device affairs outsourcing market statistics, including medical device affairs outsourcing industry global market size, regional shares, competitors with a medical device affairs outsourcing market share, detailed medical device affairs outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device affairs outsourcing industry. This medical device affairs outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical device affairs outsourcing involves contracting external specialists to manage regulatory compliance and quality assurance for medical devices, helping companies meet complex global standards more efficiently.
The primary services in medical device affairs outsourcing include regulatory writing and submissions, regulatory registration services, regulatory consulting, and others. Regulatory writing and submission services involve preparing and filing documentation required by regulatory authorities to obtain approvals for medical devices. The software solutions include cloud-based platforms and on-premise systems, and these services are used by end users such as pharmaceutical companies, medical technology firms, and others.
The medical device affairs outsourcing includes revenues earned by entities by providing services such as data management services, compliance management, and documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical device affairs outsourcing market size is expected to see strong growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of advanced regulatory software solutions, growth in outsourcing partnerships, increasing focus on strategic regulatory planning, expansion of post-market surveillance programs, integration of ai and analytics for regulatory efficiency. Major trends in the forecast period include increasing adoption of regulatory affairs outsourcing by medical device companies, rising demand for cloud-based compliance and management solutions, focus on streamlining clinical trial applications and regulatory submissions, growth in quality management system (qms) support services, enhanced post-market surveillance and risk assessment capabilities.
The increasing demand for medical devices is increasingly supporting the expansion of the medical device affairs outsourcing market going forward. Medical devices include instruments, machines, implants, and apparatuses used to diagnose, treat, or prevent medical conditions. Demand for medical devices continues to rise due to improved treatment outcomes, enhanced patient care, and expansion of healthcare infrastructure. Medical device affairs outsourcing supports manufacturers by improving regulatory compliance, streamlining operations, and accelerating market access, enabling companies to focus on innovation and core competencies. For example, in April 2024, according to the Medicines and Healthcare products Regulatory Agency, a UK-based government agency, the number of registered medical products increased from approximately 2.25 million in 2022 to around 3.25 million in 2024. As a result, the growing demand for medical devices is reinforcing expansion across the medical device affairs outsourcing market.
Leading companies operating in the medical device affairs outsourcing market are strengthening decentralized clinical trial capabilities to improve research efficiency, patient recruitment, and data quality. Decentralized clinical trials use digital tools and remote participation to enhance flexibility and accessibility while maintaining regulatory compliance. For example, in March 2023, Syneos Health, a US-based provider of contract research and commercialization services, launched a Decentralized Clinical Trial Site Network to support broader adoption of decentralized trial models. This initiative enhances trial quality, patient engagement, and evidence generation for medical device commercialization.
In June 2023, Arterex Medical, a US-based provider of medical device contract manufacturing services, acquired NextPhase Medical Devices LLC for an undisclosed amount. With this acquisition, Arterex enhances its manufacturing capabilities and positions itself for future growth in a competitive market environment. NextPhase Medical Devices LLC is a US-based company that offers medical device regulatory and quality affairs outsourcing services.
Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC.
Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device affairs outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the medical device affairs outsourcing market by increasing costs for imported software platforms and consulting services used for regulatory compliance. Segments such as cloud-based software solutions and regulatory consulting are most affected, particularly in regions like Asia-Pacific and Europe where outsourcing hubs rely on imported technology and expertise. While tariffs have created cost pressures and operational adjustments, they also encourage local development of regulatory tools and services, fostering innovation and domestic capacity building.
The medical device affairs outsourcing market research report is one of a series of new reports that provides medical device affairs outsourcing market statistics, including medical device affairs outsourcing industry global market size, regional shares, competitors with a medical device affairs outsourcing market share, detailed medical device affairs outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device affairs outsourcing industry. This medical device affairs outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical device affairs outsourcing involves contracting external specialists to manage regulatory compliance and quality assurance for medical devices, helping companies meet complex global standards more efficiently.
The primary services in medical device affairs outsourcing include regulatory writing and submissions, regulatory registration services, regulatory consulting, and others. Regulatory writing and submission services involve preparing and filing documentation required by regulatory authorities to obtain approvals for medical devices. The software solutions include cloud-based platforms and on-premise systems, and these services are used by end users such as pharmaceutical companies, medical technology firms, and others.
The medical device affairs outsourcing includes revenues earned by entities by providing services such as data management services, compliance management, and documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Device Affairs Outsourcing Market Characteristics
3. Medical Device Affairs Outsourcing Market Supply Chain Analysis
4. Global Medical Device Affairs Outsourcing Market Trends and Strategies
5. Medical Device Affairs Outsourcing Market Analysis of End Use Industries
7. Global Medical Device Affairs Outsourcing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Device Affairs Outsourcing Total Addressable Market (TAM) Analysis for the Market
9. Medical Device Affairs Outsourcing Market Segmentation
10. Medical Device Affairs Outsourcing Market Regional and Country Analysis
11. Asia-Pacific Medical Device Affairs Outsourcing Market
12. China Medical Device Affairs Outsourcing Market
13. India Medical Device Affairs Outsourcing Market
14. Japan Medical Device Affairs Outsourcing Market
15. Australia Medical Device Affairs Outsourcing Market
16. Indonesia Medical Device Affairs Outsourcing Market
17. South Korea Medical Device Affairs Outsourcing Market
18. Taiwan Medical Device Affairs Outsourcing Market
19. South East Asia Medical Device Affairs Outsourcing Market
20. Western Europe Medical Device Affairs Outsourcing Market
21. UK Medical Device Affairs Outsourcing Market
22. Germany Medical Device Affairs Outsourcing Market
23. France Medical Device Affairs Outsourcing Market
24. Italy Medical Device Affairs Outsourcing Market
25. Spain Medical Device Affairs Outsourcing Market
26. Eastern Europe Medical Device Affairs Outsourcing Market
27. Russia Medical Device Affairs Outsourcing Market
28. North America Medical Device Affairs Outsourcing Market
29. USA Medical Device Affairs Outsourcing Market
30. Canada Medical Device Affairs Outsourcing Market
31. South America Medical Device Affairs Outsourcing Market
32. Brazil Medical Device Affairs Outsourcing Market
33. Middle East Medical Device Affairs Outsourcing Market
34. Africa Medical Device Affairs Outsourcing Market
36. Medical Device Affairs Outsourcing Market Competitive Landscape and Company Profiles
37. Medical Device Affairs Outsourcing Market Other Major and Innovative Companies
40. Medical Device Affairs Outsourcing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Device Affairs Outsourcing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical device affairs outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical device affairs outsourcing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device affairs outsourcing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Service: Regulatory Writing And Submissions; Regulatory Registration Services; Regulatory Consulting; Other Services2) By Software: Cloud Based Software; On Premise Software
3) By End User: Pharmaceutical Companies; Medical Technology Companies; Other End Users
Subsegments:
1) By Regulatory Writing And Submissions: Clinical Trial Applications (CTAs); Investigational New Drug Applications (INDs); New Drug Applications (NDAs); Summary And Reports For Regulatory Agencies2) By Regulatory Registration Services: Device Registration; Market Authorization Applications (MAAs); Product Listing And Establishment Registration
3) By Regulatory Consulting: Strategic Regulatory Planning; Regulatory Compliance Audits; Labeling And Advertising Compliance
4) By Other Services: Post-Market Surveillance; Training And Education; Quality Management System (QMS) Support; Risk Management And Assessment
Companies Mentioned: IQVIA Holdings Inc; ICON PLC; PAREXEL International Corporation; Intertek Group PLC; Eurofins Scientific SE; SGS SA; TUV SUD AG; TUV Rheinland AG; UL Solutions Inc; BSI Group; RQM Plus LLC; NAMSA; Medpace Holdings Inc; WuXi AppTec Inc; Charles River Laboratories International Inc; Laboratory Corporation of America Holdings; Sterigenics International LLC; Pace Analytical Services LLC; Avania LLC; Qserve Group BV; IMed Consultancy Ltd; Global Regulatory Partners Inc; MedTech Review LLC; Clario Inc; ProPharma Group Inc; NSF Health Sciences LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Device Affairs Outsourcing market report include:- IQVIA Holdings Inc
- ICON PLC
- PAREXEL International Corporation
- Intertek Group PLC
- Eurofins Scientific SE
- SGS SA
- TUV SUD AG
- TUV Rheinland AG
- UL Solutions Inc
- BSI Group
- RQM Plus LLC
- NAMSA
- Medpace Holdings Inc
- WuXi AppTec Inc
- Charles River Laboratories International Inc
- Laboratory Corporation of America Holdings
- Sterigenics International LLC
- Pace Analytical Services LLC
- Avania LLC
- Qserve Group BV
- IMed Consultancy Ltd
- Global Regulatory Partners Inc
- MedTech Review LLC
- Clario Inc
- ProPharma Group Inc
- NSF Health Sciences LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.85 Billion |
| Forecasted Market Value ( USD | $ 7.65 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
